Advertisement
U.S. markets open in 6 hours 13 minutes
  • S&P Futures

    5,210.00
    -4.75 (-0.09%)
     
  • Dow Futures

    39,229.00
    +6.00 (+0.02%)
     
  • Nasdaq Futures

    18,187.75
    -43.75 (-0.24%)
     
  • Russell 2000 Futures

    2,048.70
    -1.10 (-0.05%)
     
  • Crude Oil

    82.59
    -0.13 (-0.16%)
     
  • Gold

    2,159.10
    -5.20 (-0.24%)
     
  • Silver

    25.14
    -0.12 (-0.49%)
     
  • EUR/USD

    1.0867
    -0.0009 (-0.09%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.33
    0.00 (0.00%)
     
  • GBP/USD

    1.2705
    -0.0023 (-0.18%)
     
  • USD/JPY

    150.2720
    +1.1740 (+0.79%)
     
  • Bitcoin USD

    63,895.24
    -4,470.16 (-6.54%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

What Falling Estimates & Price Mean for Natus Medical (BABY)

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is Natus Medical Incorporated BABY, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in BABY.

A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen one estimate moving down in the past 30 days, compared with just no upward revisions. This trend has caused the consensus estimate to trend lower, going from $1.74 a share a month ago to its current level of $1.65.

Also, for the current quarter, Natus Medical has seen one downward estimate revision versus no revisions in the opposite direction, dragging the consensus estimate down to 62 cents a share from 71 cents over the past 30 days. 

The stock also has seen some pretty dismal trading lately, as the share price has dropped 27.3% in the past month.

Natus Medical Incorporated Price and Consensus

Natus Medical Incorporated Price and Consensus | Natus Medical Incorporated Quote

So it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long time horizon to wait.

If you are still interested in the  Medical - Instruments industry, you may instead consider a better-ranked stock – Cantel Medical Corp. CMD. The stock currently holds a Zacks Rank #2 (Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank  (Strong Buy) stocks here.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Natus Medical Incorporated (BABY) : Free Stock Analysis Report
 
Cantel Medical Corp. (CMD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement